LivaNova PLC

NASDAQ:LIVN

Medical - Devices

Healthcare
$94.54 +0.96%

+$0.76 today

Market cap
$5.21B
Beta
0.88
P/E (TTM)
40.5
EPS (TTM)
$1.96
52W Low $41.02High $80.96

Volume 1.32M

Average 0.79M

LIVN Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

LivaNova PLCNASDAQ: LIVN

Gross Margin · Q3 FY2026 · quarter ended Sep 2026

Gross margin narrows to 67.4%

Gross margin was 67.4% in Q3 FY2026, down 1.0 pp from a year earlier. On a trailing-twelve-month basis it was 67.9%, down 0.6 pp year over year. Over 3 fiscal years it narrowed by 1.5 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
67.4%-2.7 pp QoQ
Last fiscal yearDec 2025
67.7%-1.8 pp YoY
LTMSep 2026
67.9%-0.6 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-1.0 pp——
1 year-1.8 pp——
3 years-1.5 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
67.7%
Year-over-year change
-1.8pp

Gross Margin vs competitors

How LIVN compares with its peers on the latest reported figures

  • LIVN's LTM Sep 2026 gross margin of 67.9% is the 6th highest of the 10 companies compared; the peer median is 71.2%.
  • Its year-over-year change of -0.6 pp is the 8th highest of 10, against a peer median of +1.8 pp.
  • Over three fiscal years its change of -1.5 pp compares with a peer median of +2.4 pp.
LIVN Competitors Peer median
Gross Margin for LIVN and competitors
Company Period LTM level YoY 3-year change
INSPInspire Medical Systems, Inc.LTM Jun 202686.1% +1.7 pp+1.6 pp
CVRXCVRx, Inc.LTM Mar 202685.5% +1.8 pp+7.6 pp
NPCENeuroPace, Inc.LTM Mar 202678.3% +3.5 pp+5.8 pp
EWEdwards Lifesciences CorporationLTM Jun 202678.0% -0.9 pp-0.2 pp
BSXBoston Scientific CorporationLTM Jun 202671.2% +7.9 pp+8.2 pp
LIVNLivaNova PLCLTM Sep 202667.9% -0.6 pp-1.5 pp
MDTMedtronic plcLTM Jul 202666.7% +3.3 pp-0.7 pp
RMDResMed Inc.LTM Jun 202661.2% +1.8 pp+5.3 pp
HAEHaemonetics CorporationLTM Jun 202657.4% +0.6 pp+2.4 pp
STIMNeuronetics, Inc.LTM Mar 202648.0% -15.6 pp-27.8 pp
MOBIMobia Medical, Inc. Common Stock—— ——
Peer median (excluding LIVN) 71.2%+1.8 pp+2.4 pp

Competitors are the stored peer set for LIVN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.04B1.02B1.15B1.25B1.39B
Cost of Revenue329.37M314.58M382.3M382.56M448.2M
Gross Profit705.99M707.23M771.25M870.87M939.9M
Gross Margin68.2%69.2%66.9%69.5%67.7%
Research & Development183.41M155.81M193.82M182.51M185.8M
Selling, General & Admin471.9M469.24M518.13M526.27M548.8M
Operating Expenses706.78M783.98M839.75M741.82M740.5M
Depreciation & Amortization67.99M57.8M60.86M51.14M42M
EBITDA(6.33M)30.9M38.48M202.52M(129.5M)
EBITDA Margin-0.6%3.0%3.3%16.2%-9.3%
Operating Income(784K)(76.75M)(68.5M)129.05M199.4M
Operating Margin-0.1%-7.5%-5.9%10.3%14.4%
Interest Income435K4.7M22.01M30.08M18.98M
Interest Expense50.15M48.25M58.85M63.07M49.29M
Other Income / Expenses(123.84M)1.56M(12.83M)(40.74M)(420.2M)
Income Before Tax(124.62M)(75.2M)(81.33M)88.31M(220.8M)
Pre-Tax Margin-12.0%-7.4%-7.1%7.0%-15.9%
Income Tax Expense11.2M11.05M(98.88M)25.06M21.6M
Net Income(135.82M)(86.25M)17.55M63.23M(242.5M)
Net Margin-13.1%-8.4%1.5%5.0%-17.5%
EPS (Basic)(2.68)(1.61)0.331.17(4.45)
EPS (Diluted)(2.68)(1.61)0.321.16(4.45)
Weighted Avg Shares50.63M53.5M53.9M54.24M54.5M
Weighted Avg Shares (Diluted)50.63M53.5M54.21M54.57M54.5M

LivaNova PLC

NASDAQ:LIVN

Intrinsic Alpha fair value

Locked

Current Price

$94.54

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.